Protective effect of tumor necrosis factor α antibody on experimental necrotizing enterocolitis in the rat

Journal of Pediatric Surgery

Volumn 40, Issue 9, 2005, Pages 1440-1445

  Seitz, Guido ^a   Warmann, Steven W ^a   Guglielmetti, Andres ^a   Heitmann, Heike ^a   Ruck, Peter ^b   Kreis, Martin E ^a   Fuchs, Jörg ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Krankenhaus Leonberg   (Germany)

Author keywords

Necrotizing enterocolitis; Proinflammatory cytokines; TNF

Indexed keywords

MYELOPEROXIDASE; NEUTRALIZING ANTIBODY; T 0938; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL MILK; COLD EXPOSURE; CONTROLLED STUDY; DISEASE SEVERITY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE; TREATMENT OUTCOME;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; DIET; DISEASE MODELS, ANIMAL; ENTEROCOLITIS, NECROTIZING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 24344474826     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2005.05.043     Document Type: Article

References (41)

1. M.S. Caplan, and W. MacKendrick Necrotizing enterocolitis: a review of pathogenetic mechanism and implications for prevention Pediatr Pathol 13 1993 357 369
2. N.N. Nanthakumar, R.D. Fusunyan, and I. Sanderson Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis Proc Natl Acad Sci U S A 97 2000 6043 6048
3. M.S. Caplan, E. Hedlund, and L. Adler Role of asphyxia and feeding in a neonatal rat model of necrotizing enterocolitis Pediatr Pathol 14 1994 1017 1028
4. M.D. Halpern, H. Holubec, and J.A. Dominiguez Up-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis Pediatr Res 51 6 2002 733 739
5. B. Dvorak, M.D. Halpern, and H. Holubec Maternal milk reduces severity of necrotizing enterocolitis and increases intestinal IL-10 in a neonatal rat model Pediatr Res 53 3 2003 426 433
6. E.P. Nadler, A. Stanford, and X.R. Zhang Intestinal cytokine gene expression in infants with acute necrotizing enterocolitis: interleukin-11 mRNA correlates with extent of disease J Pediatr Surg 36 8 2001 1122 1129
7. H. Öztürk, A.I. Dokucu, and C. Ögun Protective effects of recombinant human interleukin-10 of hypoxia-induced necrotizing enterocolitis in immature rats J Pediatr Surg 37 9 2002 1330 1333
8. M.B. Edelson, C.E. Bagwell, and H.J. Rozycki Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis Pediatrics 103 1999 771 776
9. H. Ford, S. Watkins, and K. Reblock The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis J Pediatr Surg 32 1997 275 282
10. B.H. Zhang, H.G. Yu, and Z.X. Sheng The therapeutic effect of recombinant human trefoil factor 3 on hypoxia-induced necrotizing enterocolitis in immature rats Regul Pept 116 2003 53 60
11. M. Akisu, M. Baka, and M. Yalaz Supplementation with Saccharomyces boulardii ameliorates hypoxia/reoxygenation-induced necrotizing enterocolitis in young mice Eur J Pediatr Surg 13 2003 319 323
12. M.S. Caplan, and W. Hsueh Necrotizing enterocolitis: role of platelet activating factor, endotoxin, and tumor necrosis factor J Pediatr 117 1990 S47 S51
13. M. Marini, G. Bamlas, and J. Rivera-Nieves TNF-α neutralization ameliorates the severity of murine Crohn's like ileitis by abrogation of intestinal epithelial cell apoptosis Proc Natl Acad Sci U S A 14 2003 8366 8371
14. K.A. Papadakis, and S.R. Targan Tumor necrosis factor: biology and therapeutic inhibitors Gastroenterol 119 2000 1148 1157
15. J.M.H. Van den Brande, H. Braat, and G.R. van den Brink Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease Gastroenterol 124 2003 1774 1785
16. S.R. Targan, S.B. Hanauer, and S.J. van Deventer A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's disease cA2 study group N Engl J Med 337 1997 1029 1035
17. M.S. Caplan, M. Lickermann, and L. Adler The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis Pediatr Res 42 6 1997 779 783
18. L.K. McCullough, Y. Takahashi, and T. Lee Attenuated febrile response to lipopolysaccharide in rats with biliary obstruction Am J Physiol Gastrointest Liver Physiol 279 2000 G172 G177
19. W.J. De Jonge, and R.M. Wijngaard Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice Gastroenterology 125 4 2003 1137 1147
20. B. Dawson-Saunders, and R.E. Trapp Basic and clinical biostatistics 1994 Apleton and Lange Stamford, CO
21. K.D. Crissinger, and D.N. Granger Characterization of intestinal collateral blood flow in the developing piglet Pediatr Res 24 1988 473 476
22. M. Di Lorenzo, J. Bass, and A. Krantis An experimental model of necrotizing enterocolitis in the developing neonatal piglet J Pediatr Surg 30 1995 1138 1142
23. O.M. Goldblum, I.R. Holzman, and S.E. Fisher Intragastric feeding in the neonatal dog. Its effect on intestinal osmolality Am J Dis Child 135 1981 631 633
24. W.I. Garstin, B.D. Kenny, and D. McAneaney The role of intraluminal tension and pH in the development of necrotizing enterocolitis: an animal model J Pediatr Surg 22 1987 205 207
25. I.H. Krasna, C. Howell, and A. Vega A mouse model for the study of necrotizing enterocolitis J Pediatr Surg 21 1986 21 26
26. B. Barlow, T.V. Santulli, and W.C. Heird An experimental study of acute necrotizing enterocolitis-the importance of breast milk J Pediatr Surg 9 1974 587 595
27. K.D. Crissinger, D.L. Burney, and O.R. Velasquez An animal model of necrotizing enterocolitis induced by infant formula and ischemia in developing piglets Gastroenterol 106 1994 1215 1222
28. A. Antilla, H. Kauppinen, and A. Koivusalo T-cell-mediated mucosal immunity is attenuated in experimental necrotizing enterocolitis Pediatr Surg Int 19 2003 326 330
29. M.C. Harris, A.T. Costarino, and J.S. Sullivan Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis J Pediatr 124 1994 105 111
30. M.D. Halpern, H. Holubec, and J.A. Dominguez Hepatic inflammatory mediators contribute to intestinal damage in necrotizing enterocolitis Am J Physiol Gastrointest Liver Physiol 284 2003 G695 G702
31. B.H. Zhang, H.G. Yu, and Z.X. Sheng The therapeutic effect of recombinant human trefoil factor 3 on hypoxia-induced necrotizing enterocolitis in immature rats Regul Pept 116 1-3 2003 53 60
32. S.L.F. Pender, C. Braegger, and U. Günther Matrix metalloproteinases in necrotizing enterocolitis Pediatr Res 54 2 2003 160 164
33. M. Leonardo, K.M. Chan, and F. Hornung Mature T lymphocytes apoptosis-immune regulation in a dynamic and unpredictable antigenic environment Annu Rev Immunol 17 1999 221 253
34. S. Bang, E.J. Jeong, and I.K. Kim Fas- and tumor necrosis factor-mediated apoptosis uses the same binding surface of FADD to trigger signal transduction. A typical model for convergent signal transduction J Biol Chem 275 2000 36217 36222
35. P. Rutgeerts, S. van Deventer, and S. Schreiber Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease-focus on selective adhesion molecule inhibition Aliment Pharmacol Ther 17 2003 1435 1450
36. B.J. Scallon, M.A. Moore, and H. Trinh Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions Cytokine 7 1995 251 259
37. P. Suenart, V. Bulteel, and L. Lemmens Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease Am J Gastroenterol 97 8 2002 2000 2004
38. S.B. Hanauer, B.G. Feagan, and G.R. Lichtenstein Maintenance infliximab for Crohn's disease: the ACCENT 1 randomised trial Lancet 359 2002 1541 1549
39. A. Alldred Etanercept in rheumatoid arthritis Expert Opin Pharmacother 2 2001 1137 1148
40. J. Keane, S. Gershon, and R.P. Wise Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent N Engl J Med 345 2001 1098 1104
41. J.R. Bebb, and R.P. Logan Review article: does the use of immunosuppressive therapy in inflammatory bowel disease increase the risk of developing lymphoma? Aliment Pharmacol Ther 15 2001 1843 1849